06/18/2026 | Press release | Distributed by Public on 06/18/2026 07:20
The National Association of Chain Drug Stores (NACDS) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on a proposed rule on prior authorization for prescription drugs and interoperability (CMS-0062-P), urging the agency to ensure the proposals work within real-world pharmacy workflows and reduce the administrative burdens that delay patient access to medications.
NACDS supports CMS' goal of expanding electronic prior authorization, advancing data exchange, and reducing administrative burden. However, the Association cautioned that the proposal remains oriented around payers and prescribers without fully accounting for pharmacies - the very setting where coverage and prior authorization barriers are most acutely encountered.
"NACDS appreciates CMS' leadership in advancing interoperability and prior authorization reform, and we support the rule's overall direction," said NACDS President and CEO Steven C. Anderson, FASAE, CAE, IOM. "But to deliver meaningful improvement for patients, the final rule must do more than expand data exchange requirements - it must ensure those requirements work in real-world workflows, particularly in pharmacy settings where coverage requirements and patient care needs converge."
In its comments, NACDS recommended that CMS:
"Pharmacists are frequently the first to identify a coverage barrier and the closest point of contact for the patient who needs their medication," Anderson said. "When information is not actionable, that burden falls on pharmacy teams - and on patients. Reform should reduce that burden and improve access, not simply shift it downstream."